@article{2c7603be29cc4780804a27c22d0c0a72,
title = "Antivirals against the Chikungunya Virus",
keywords = "Chikungunya virus, alphavirus, antiviral therapy, direct-acting antivirals, host-directed antivirals, in silico screening, in vivo validation, antiviral drug development, SEMLIKI-FOREST-VIRUS, IN-VITRO, SELECTIVE INHIBITORS, SURAMIN TREATMENT, INTERFERON-ALPHA, INFECTION, REPLICATION, CHLOROQUINE, DERIVATIVES, RIBAVIRIN, Antiviral drug development, In silico screening, In vivo validation, Antiviral therapy, Host-directed antivirals, Alphavirus, Direct-acting antivirals, Humans, Virus Replication/drug effects, Computer Simulation, Chikungunya Fever/drug therapy, Disease Models, Animal, Chikungunya virus/drug effects, Animals, Antiviral Agents/pharmacology, Culicidae, Mice, Drug Development",
author = "Verena Battisti and Ernst Urban and Thierry Langer",
note = "Publisher Copyright: {\textcopyright} 2021 by the authors. Licensee MDPI, Basel, Switzerland.",
year = "2021",
month = jul,
day = "5",
doi = "10.3390/v13071307",
language = "English",
volume = "13",
journal = "Viruses",
issn = "1999-4915",
publisher = "MDPI AG",
number = "7",
}
